Versicor (VERS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Versicor (VERS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (40)	3/30/2003 12:34:49 PM
From: tuck	Read Replies (2) of 83

Thought folks might like to know BioSpace's Dr. Garren likes VERS -- now MICU, having changed its name to Viculon (why? many feel name changes are a red flag, our esteemed Peter among them): biospace.com He comes to the same conclusions about the PIII results that we have. The follow-up data is immaterial to the main indications MICU is going after. He also notes Fujisawa's drug is on the same timeline now that the FDA has asked for more data. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next